So… this NIH study will test this theory on prim

So… this NIH study will test this theory on primates and block CCR5 receptors with this AAV method that is a permanent blocking of the CCR5 receptor. Or really it teaches our immune system to produce Leronlimab permanently is what I read somewhere. Isn’t it also true that some people do not have the CCR5 receptor? So… if people don’t need the CCR5 receptor and Leronlimab will block it forever. All the diseases that travel through our system through the CCR5 receptor will be defeated and no longer impactful to anyone. So the 89+ diseases on the OHM20 list could all show benefit or cure from vaccination status for those diseases? Wow…

Hmmm… The impact of such a change in how we protect or vaccinate the world could change forever. Just think about what is possible here. How many diseases could we tackle with just one dose of AAV Leronlimab? This is quite exciting and I hope the primate trials go well and we move on to human trials inside of the 5 years. Possible break throughs like this are just amazing to me and to factor all the possibilities is unreal and exciting.

As investors we just may change some nasty diseases that will not impactful any longer to the world. It really gives us the time to ponder such a reality and I know it seems not possible but what if this was achievable? What if? We very well could have something very big here… let your imagination ponder this possibility for awhile. It looks possible… maybe it is possible.